Toxicology Consultancy for Pharmaceuticals & Medical Devices
Toxicology consultancy support is becoming increasingly important for pharmaceutical and medical device companies as toxicological and regulatory requirements continue to evolve. Companies developing new products are expected to establish a clear preclinical strategy, assess risks associated with impurities and nitrosamines, evaluate biological safety, and prepare scientifically justified documentation for regulatory submissions. As a result, many companies rely on experienced toxicology consultants and specialized toxicology consulting services to support efficient development and compliance with EMA, FDA, ICH, and ISO expectations.
In practice, development teams often face challenges translating complex regulatory requirements into efficient development strategies. Toxicological gaps identified late in development can lead to additional authority questions, delayed clinical timelines, increased costs, or setbacks during registration.
A structured toxicology consultancy approach helps companies support safer product development, minimize regulatory risk, and prepare toxicological documentation aligned with current global expectations.